ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 12 of 26 for:    Recruiting, Not yet recruiting, Available Studies | "Amblyopia"

AMblyopia Treatment Through PErceptual Training in Children (AMPEL) (AMPEL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02555384
Recruitment Status : Not yet recruiting
First Posted : September 21, 2015
Last Update Posted : May 4, 2018
Sponsor:
Collaborator:
University Medical Center Nijmegen
Information provided by (Responsible Party):
Anja Palmowski-Wolfe, University of Basel

Brief Summary:

Amblyopia, affects 4% of the population. In the presence of a normal retina and optic nerve, the visual cortex does not develop normally secondary to the amblyopic eye being at a disadvantage in the sensitive period such as in strabismus. Amblyopia is associated with visuospatial disorders, and poor to absent stereopsis. Amblyopia is treated by occlusion of the non- amblyopic eye in childhood. The present study aims to evaluate the effectiveness of perceptual learning (PL), that is a training of visual drawing tasks (12 sessions of 30 Minutes duration) with crowding (c) for children with amblyopia compared to an amblyopic control group with a placebo drawing task.

Arm 1: Crowded (PLc)- Training with small spacing Arm 2: Uncrowded (PLu)- Training with large spacing Prior to this, a small group will help optimize parameters such as contrast and distance of visual objects presented


Condition or disease Intervention/treatment Phase
Strabismic Amblyopia Other: crowded drawing task Other: uncrowded drawing task Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Improving Visual Functions in Young Children With Amblyopia Through Perceptual Learning
Estimated Study Start Date : January 2019
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : June 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Amblyopia

Arm Intervention/treatment
Active Comparator: crowded drawing task
children will be asked to draw on a pattern presented under crowded viewing conditions.
Other: crowded drawing task
Marking inverted signs on a sheet where symbols are presented close to one another

Placebo Comparator: uncrowded drawing task
children will be asked to draw on a pattern presented under uncrowded viewing conditions
Other: uncrowded drawing task
Marking inverted signs on a sheet where there is a larger distance between symbols




Primary Outcome Measures :
  1. Crowding Ratio (CR) [ Time Frame: 7 weeks ]
    CR= Ratio of crowded versus uncrowded visual acuity. This is compared pre to post treatment


Secondary Outcome Measures :
  1. hand-eye coordination [ Time Frame: 7 weeks ]
    Outcome of a Beery test


Other Outcome Measures:
  1. longterm effect on CR [ Time Frame: 7 months ]
    CR Follow up 6 months after end of drawing training

  2. macular structure [ Time Frame: 7 weeks and 7 months ]
    comparison of macular optical coherence tomography scan pre and post training



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Years to 8 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: children aged 4-8 years with

  • strabismic amblyopia
  • cycloplegic refraction corrected at least 3 months prior to enrolment
  • Reliable test results for two previous examinations
  • absence of ocular conditions other than strabismus, amblyopia and corrected refractive error

Exclusion Criteria:

  • inability to perform reliably when examined
  • inability to draw
  • unstable visual results on 2 previous examinations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02555384


Contacts
Contact: Anja M Palmowski-Wolfe, Prof. med. 004161265 ext 8722 Anja.Palmowski-Wolfe@usb.ch

Sponsors and Collaborators
University of Basel
University Medical Center Nijmegen
Investigators
Principal Investigator: Anja M Palmowski-Wolfe, Prof. med. University Basel, Eye Hospital

Publications:
Responsible Party: Anja Palmowski-Wolfe, Prof. Dr.med., University of Basel
ClinicalTrials.gov Identifier: NCT02555384     History of Changes
Other Study ID Numbers: EKNZ2015-264
First Posted: September 21, 2015    Key Record Dates
Last Update Posted: May 4, 2018
Last Verified: May 2018

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Amblyopia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vision Disorders
Sensation Disorders
Neurologic Manifestations
Eye Diseases
Signs and Symptoms